KEAP1 and cerebrotendinous xanthomatosis: Animal experiments showed that 50 mg/kg EBF and 100 mg/kg EBF doses could reduce the increase in MDA, BUN, Cre, GPT/ALT, and IL-6 levels caused by CTX; Keap1 protein expression was decreased and Nrf2 protein expression was enhanced in renal tissue.